WHO drops two trial arms for COVID-19 treatment

health professional at computer with magnifying glass
The World Health Organization has discontinued the Solidarity Trial’s hydroxychloroquine and lopinavir/ritonavir arms as interim results show little or no benefit WHO has accepted the trial’s International Steering Committee recommendation to discontinue the two trial arms, based on evidence from interim results for hydroxychloroquine vs standard of care and for lopinavir/ritonavir vs standard of care,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pharmacy-owning GP next door disqualified
Next Pandemic guidance